Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1956 of 5804
-
Blood test may spot Alzheimer's without painful spinal tap
Diagnosis CompletedAlzheimer's disease (AD) has gradually become one of the major global public health issues due to its prevalence, which increases with age and life expectancy, and the economic cost of caring for patients whose cognitive decline progressively leads to loss of functional autonomy.…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
Scientists probe the genetic origins of menstruation by comparing human and primate uterine tissue
Knowledge-focused OngoingMenstruation corresponds to the shedding of the uterine lining when fecundation has not occurred. This is a recent evolutionary innovation in primates, and the cellular and genetic changes that led to the acquisition of menstruation are not well understood. Additionally, the uter…
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
New study aims to boost genetic cancer testing in black communities
Knowledge-focused Recruiting nowTo identify Black individuals who are eligible for genetic testing through trusted community organizations, and to connect Black individuals and their families to genetic testing and counseling so that they can know their cancer risk and how to decrease it.
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
New COVID booster vaccine shows promise in early trial
⭐️ VACCINE ⭐️ CompletedSpiN-Tec MCTI UFMG will be used as a vaccine booster against COVID-19 and will be evaluated using the active comparator, a vaccine approved by ANVISA (Brazilian Health Regulatory Agency). The study will consist of two parts: Part A) a Phase 1 dose-escalation clinical trial to ass…
Phase: PHASE1, PHASE2 • Sponsor: Federal University of Minas Gerais • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 17:23 UTC
-
New score could spot kidney failure early in heart surgery patients
Diagnosis CompletedThe prediction and early detection of acute renal failure associated with cardiac surgery (ARF-CS) are desirable in order to try to reduce its magnitude. Indeed, its incidence is high (29 to 36%, reaching up to 81% in some series, depending on the vulnerability of the target popu…
Sponsor: Nantes University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:14 UTC
-
New mesh aims to stop hernias after belly surgery
Prevention OngoingThe purpose of this prospective, pivotal, multi-center, single-arm, pre-market, investigational clinical study is to assess the safety and performance of Deternia™ Self-Gripping Resorbable Mesh when used for suture line reinforcement after midline laparotomy in clean and clean-co…
Phase: NA • Sponsor: Medtronic - MITG • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Vitamin B3 dose trial hopes to slow Alzheimer's brain decline
Disease control CompletedThe goal of this double-blinded placebo-controlled randomized trial is to determine the optimal dose of nicotinamide riboside (NR), in individuals with Alzheimer's disease (AD). The main questions the N-DOSE AD trial aims to answer are: What dose of nicotinamide riboside (NR) i…
Phase: PHASE2 • Sponsor: Haukeland University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New oral drug EP395 tested for COPD safety
Disease control CompletedThe aim of this clinical trial is to investigate the safety and tolerability of oral, once-daily EP395 administration in COPD patients for 12 weeks.
Phase: PHASE2 • Sponsor: EpiEndo Pharmaceuticals • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Old drug, new hope: niclosamide tested for tough childhood leukemia
Disease control Recruiting nowProtocol is designed to evaluate a niclosamide dose escalation scale in combination with cytarabine as a therapeutic modality for pediatric subjects with relapsed/refractory acute myeloid leukemia.
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Hidden heart risk: study aims to catch deadly protein buildup before symptoms start
Knowledge-focused Recruiting nowApproximately 1.5 million of the 44 million Blacks in the United States are carriers of the valine-to-isoleucine substitution at position 122 (V122I) in the transthyretin (TTR) protein. Virtually exclusive to Blacks, this is the most common cause of hereditary cardiac amyloidosis…
Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Can a metabolic diet prevent relapse in anorexia? new study seeks answers
Disease control Recruiting nowThis is an interventional study that will test the safety, tolerability, and efficacy of the Metabolic Diet, which was designed as a treatment for women with anorexia nervosa to remain weight-stable after they have been restored from low weight. Participants will be adult women w…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Can MRI replace unnecessary biopsies for prostate cancer patients?
Knowledge-focused Recruiting nowBackground: Active surveillance (AS) is a standard approach to treat low and intermediate risk prostate cancer. For AS, disease progression is monitored. AS uses biopsies, prostate specific antigen (PSA) blood tests, and other tools. Researchers want to see if multiparametric ma…
Phase: NA • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Can your genes predict which eye drug works best?
Knowledge-focused Recruiting nowThis is a phase III, multicenter, randomized double-blinded clinical trial with two parallel groups (ranibizumab and bevacizumab) and an observational follow-up of patients who meet elegibility criteria and decline participation due to treatment randomization. It will be performe…
Phase: PHASE3 • Sponsor: Parc de Salut Mar • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
New wearable pump could send heart failure patients home early
Symptom relief CompletedTo investigate whether an early supported discharge strategy for patients admitted to hospital because of HF, using a pH neutral subcutaneous (SC) furosemide formulation (SQINFurosemide) at home (delivered by non-CE marked SQINInfusor), compared to a usual care strategy with intr…
Phase: PHASE2 • Sponsor: NHS Greater Glasgow and Clyde • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Massive breast cancer registry seeks 200,000 volunteers to fuel research
Knowledge-focused Recruiting nowShareForCures (SFC) is a community-based participatory research registry, and its prime objective is to engage participants representative of the United States breast cancer patient population -including minoritized and historically marginalized people, persons, or communities-to…
Sponsor: Susan G. Komen Breast Cancer Foundation • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
At-Home HPV test could revolutionize cervical cancer screening
Diagnosis CompletedThe purpose of this study is to validate a patient self-sampling vaginal collection kit and laboratory testing for the detection of HPV (human papillomavirus) infection. Researchers will compare the laboratory results of self-collected vaginal swab samples to usual healthcare pro…
Phase: NA • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
New MRI-Guided radiation aims to cut prostate cancer treatment time
Disease control TerminatedThis phase II trial tests whether magnetic resonance imaging (MRI)-guided hypofractionated radiation therapy works to reduce treatment time and side effects in patients with high risk prostate cancer. MRI-guided hypofractionated radiation therapy delivers higher doses of radiatio…
Phase: PHASE2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Short exercise program may cut heart risk in arthritis patients
Disease control CompletedThe aim of this study is to investigate the beneficial impacts of the 6-week standardized CR program applied to hypertensive RA patients whose disease activity is under control with regular pharmacological treatment. Subjects will be randomly assigned to one of two groups: 1.) s…
Phase: NA • Sponsor: Kayseri City Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Knee injection study hopes to ease arthritis pain in children
Symptom relief CompletedThe purpose of this study is to evaluate the short-term clinical effects of intra-articular corticosteroid injections on knee joint functions in children and adolescents diagnosed with Juvenile Idiopathic Arthritis (JIA). Patients who receive a corticosteroid injection into the …
Sponsor: Necmettin Erbakan University • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
New laser aims to sharpen vision for the farsighted
Symptom relief OngoingThis will be a multicenter, prospective, open label, non-randomized, single arm 12 month study, evaluating the safety and effectiveness of the TECHNOLAS TENEO 317 Model 2 (Software version "1.28 US") excimer laser when used in LASIK surgery to treat hyperopia with or without hype…
Phase: NA • Sponsor: Bausch & Lomb Incorporated • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC